Lorazepam

Product NDC
0615-8003
11-digit product format
006158003
Labeler code
0615
Product ID
0615-8003_8c995d4f-2a20-4210-bfff-08c9183db168
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
lorazepam
Dosage form
TABLET
Route
ORAL
Labeler
NCS HealthCare of KY, Inc dba Vangard Labs
Application
ANDA077754
Marketing category
ANDA
Marketing start
2006-05-10
Marketing end
0000-00-00
Substance
LORAZEPAM
Active strength
1 mg/1
Pharmacologic classes
Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0615-8003DDiscontinued by firm2026-08-03
excluded packagepackage0615-80030615-8003-39DDiscontinued by firm2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077754-001LORAZEPAMLORAZEPAM0.5MGTABLET / ORALAB2006-05-10
A077754-002LORAZEPAMLORAZEPAM1MGTABLET / ORALAB2006-05-10
A077754-003LORAZEPAMLORAZEPAM2MGTABLET / ORALAB2006-05-10

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A077754-001AB
A077754-002AB
A077754-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A077754-001LORAZEPAM0.5MGTABLET / ORALAB2006-05-10a50c72e98297…
2026-08-01 22:54:322026-06A077754-002LORAZEPAM1MGTABLET / ORALAB2006-05-10a50c72e98297…
2026-08-01 22:54:322026-06A077754-003LORAZEPAM2MGTABLET / ORALAB2006-05-10a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06A077754-001AB1a50c72e98297…
2026-08-01 22:54:322026-06A077754-002AB1a50c72e98297…
2026-08-01 22:54:322026-06A077754-003AB1a50c72e98297…

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0615-8003-392021-07-09C16284748780-19d75b9d0-f12d-f424-e053-dadaa90a57ceLORAZEPAM TABLETS, USP CIV Rx only
0615-8003-392020-01-31C16284748780-19d75b9d0-f12d-f424-e053-dadaa90a57ceLORAZEPAM TABLETS, USP CIV Rx only